The MTI directory allows you to search for companies by expertise, organized under three therapeutic solutions.

Genetical therapy

A gene therapy drug is a product obtained by a set of manufacturing processes aimed at the transfer of a prophylactic, diagnostic or therapeutic gene in humans and its consecutive expression in vivo. The transfer of a gene involves an expression system contained in an administration system called a vector which can be of viral or non-viral origin.

A gene therapy drug is a biological drug. Its characteristics are as follows:
a) Its active substance contains or constitutes a recombinant nucleic acid administered to persons for the purpose of regulating, repairing, replacing, adding or removing a genetic sequence
b) Its therapeutic, prophylactic or diagnostic effect depends directly on the recombinant nucleic acid sequence it contains or on the product of the gene expression of this sequence.

Cellular products for therapeutic purposes are human cells used for autologous therapeutic ((that is to say, the donor and the recipient are the same person) or allogenic, (the recipient and the donor are then two different people) whatever the level of transformation, including their derivatives.

A cell therapy drug is a biological drug. Its characteristics are as follows:
a) It contains or consists of:
- cells, tissues which have undergone substantial manipulation to modify their biological characteristics, physiological functions or structural properties, useful for the therapy, regeneration, repair or replacement sought.
- or cells or tissues which are not intended to be used for the same essential function or functions in the recipient and the donor
b) It is presented as having properties making it possible to treat, prevent or diagnose a disease through the metabolic, immunological or pharmacological action of its cells or tissues, Or used in a person or administered to a person for such a purpose.